Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Momentum behind brain-computer interfaces is growing, but experts say that design innovations are needed to help them survive ...
Apple has teamed up with Synchron to develop tech that lets people control its devices with thoughts
Apple has partnered with brain-computer interface maker Synchron to develop tech that lets consumers control devices like iPhones with their thoughts, according to a report by the Wall Street Journal.
Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...
Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results